Atom Investors’s ResMed RMD Stock Holding History

Atom Investors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Buy	+1,253	New	+$260K	0.02%	731
2024 Q1	–	Sell	-2,009	Closed	-$346K	–	657
2023 Q4	$346K	Sell	2,009 -1,826	-48%	-$281K	0.06%	339
2023 Q3	$567K	Buy	+3,835	New	+$693K	0.13%	210
2020 Q4	–	Sell	-4,576	Closed	-$784K	–	536
2020 Q3	$784K	Buy	+4,576	New	+$845K	0.07%	218
2019 Q4	–	Sell	-2,307	Closed	-$312K	–	297
2019 Q3	$312K	Sell	2,307 -699	-23%	-$91.6K	0.02%	241
2019 Q2	$367K	Sell	3,006 -10,597	-78%	-$1.17M	0.02%	327
2019 Q1	$1.41M	Buy	+13,603	New	+$1.4M	0.12%	153

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Atom Investors's RMD Position: Q2 2026 in Review

Atom Investors opened a new position in ResMed (RMD) in Q2 2026: 1,253 shares worth $244K. The stake represents 0.02% of the portfolio and ranks #731 among its holdings. This is a return to the name: Atom Investors previously reported a position in RMD as recently as Q4 2023.

Atom Investors first reported a position in RMD in Q1 2019 and has held it in 7 quarters since. The position peaked at $1.41M in Q1 2019. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Atom Investors held 1,253 shares of ResMed worth $244K as of Q2 2026.
ResMed was a new Atom Investors position in Q2 2026.
ResMed made up 0.02% of Atom Investors's portfolio in Q2 2026, its #731 holding.
Atom Investors first reported a position in ResMed in Q1 2019 and has held it in 7 quarters since.
Atom Investors's ResMed position peaked at $1.41M in Q1 2019.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.